Sit Investment Associates’s Akoya BioSciences AKYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,854
Closed -$2K 517
2025
Q2
$2K Hold
1,854
﹤0.01% 521
2025
Q1
$3K Hold
1,854
﹤0.01% 519
2024
Q4
$4K Hold
1,854
﹤0.01% 527
2024
Q3
$5K Hold
1,854
﹤0.01% 535
2024
Q2
$4K Hold
1,854
﹤0.01% 531
2024
Q1
$9K Hold
1,854
﹤0.01% 517
2023
Q4
$9K Hold
1,854
﹤0.01% 529
2023
Q3
$9K Hold
1,854
﹤0.01% 526
2023
Q2
$14K Hold
1,854
﹤0.01% 539
2023
Q1
$15K Hold
1,854
﹤0.01% 523
2022
Q4
$18K Buy
+1,854
New +$22.8K ﹤0.01% 529

Sit Investment Associates's AKYA Position: Q3 2025 in Review

Sit Investment Associates sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 1,854 shares — an estimated $2K sold.

Sit Investment Associates first reported a position in AKYA in Q4 2022 and held it in 11 quarters. The position peaked at $18K in Q4 2022. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.

  • Sit Investment Associates reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
  • Sit Investment Associates sold 1,854 Akoya BioSciences shares in Q3 2025, an estimated $2K.
  • Sit Investment Associates first reported a position in Akoya BioSciences in Q4 2022 and held it in 11 quarters.
  • Sit Investment Associates's Akoya BioSciences position peaked at $18K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.

Based on Sit Investment Associates's 13F filing for Q3 2025, filed 13 Nov 2025.